METEOR BIOTECH
LIVE

Serial Number

79411347

Owner

Meteor Biotech Co., Ltd.

Attorney

Minchul Yang

Filing Date

May 29, 2024

Add to watchlist:

No watchlists yet
View on USPTO

METEOR BIOTECH Trademark

Serial Number: 79411347 • Registration: 8090562

METEOR BIOTECH is a trademark filed by Meteor Biotech Co., Ltd. on May 29, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Meteor Biotech Co., Ltd. (5 trademarks)

(Sillimdong) 401, 117, Sillim-ro, Gwanak-gu

Entity Type: 03

Trademark Details

Filing Date

May 29, 2024

Registration Date

January 6, 2026

Published for Opposition

November 18, 2025

Goods & Services

Medical analysis for the diagnosis and treatment of persons; Medical laboratory analysis services relating to the treatment of persons; Medical services relating to the removal, treatment and processing of human blood; RNA or DNA analysis being medical analysis services for the diagnosis of cancer; Medical analysis services for the diagnosis of cancer; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Provision of genetic testing for medical purposes; Provision of information for medical purposes in the field of gene therapy for cancer treatment; Medical diagnostic services; medical screening; Genetic counseling for medical purposes; Medical analysis services of biomarkers for diagnostic purposes provided by medical laboratories

Biomarker discovery services being medical research; Custom design and development of equipment for manufacturing pharmaceuticals; Biological laboratory services relating to the selection and screening of biomarkers in biological tissue samples for scientific research purposes; Design and development of equipment for selection and screening of biomarkers in in biological tissue samples; Scientific research for medical purposes in the area of cancerous diseases; Consulting services in the field of biological sequence processing and analysis for medical research purposes; Research in the field of gene expression analysis; Development of computer software for use with medical equipment; Providing computer software technical support services, namely, troubleshooting of computer software problems in the field of medical diagnostics; Product development in the field of medical diagnostic devices; Blood testing services for medical research purposes

Reagents for medical use; Drugs for medical purposes, namely, acetaminophen; Enzymes for medical purposes; Enzyme preparations for medical purposes; Nucleic acid sequences for medical and veterinary purposes; Diagnostic chemical preparations for medical purposes for use in DNA analysis; In vitro diagnostic preparations for medical purposes; Diagnostic test reagents for medical or veterinary purposes; Chemical reagents for medical or veterinary purposes; Reagents for use in medical genetic testing

Diagnostic apparatus for research laboratory use for DNA analysis; Laboratory devices for DNA sequencing, not for medical purposes; Laboratory devices for analyzing polynucleic acid, not for medical purposes; Reagent containers being chips having multi-well arrays for use with protein analysis apparatus used in chemical analysis and biological analysis for laboratory research use; Laboratory devices for analyzing and extracting genes, not for medical purposes; DNA chips; Laboratory apparatus and instruments for preparing nucleic acid samples; Laboratory apparatus, namely, devices for analyzing protein sequences, not for medical purposes; Plates having multi-well arrays for analyzing genes for laboratory research use

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 21, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 4, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 4, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 6, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 6, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 6, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 16, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 15, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 29, 2025 GNFN
FINAL REFUSAL E-MAILED
Sep 29, 2025 GNFR
FINAL REFUSAL WRITTEN
Sep 29, 2025 CNFR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 5, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 5, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jul 5, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 1, 2025 TROA
REFUSAL PROCESSED BY IB
Jan 17, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 2, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jan 2, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 14, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 13, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 10, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 6, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 5, 2024 REPR